AlphaVax Company
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer.
Employee Number:
51-100
Funding Status:
Late Stage Venture
Headquarters:
Durham, North Carolina, United States
Technology:
Data-driven Technologies
Estimated Revenue:
$10M to $50M
Founded Date:
1997
Industry:
PharmTech